NVOS Novo Integrated Sciences Corp Sotuvning yalpi rentabelligi

Novo Integrated (NVOS) kompaniyasining rasmiy ramzlari

Diversifikatsiyalashgan tibbiy holding yaratishning spekulyativ salohiyati Novo Integrated Sciences (NVOS) aksiyalarining narx dinamikasiga ta'sir ko'rsatmoqda, bu esa yanada yalpi foyda marjasi tendentsiyasi bilan qo'llab-quvvatlanmoqda. 0.00 belgisi birlamchi tibbiy yordam va rehabilitatsiya ko'rsatishga asoslangan rentabellik darajasini ko'rsatadi. Shu bilan birga, operatsion ko'rsatkichlarning barqarorligi sog'liqni saqlash mahsulotlarining mintaqaviy omborlar orqali samarali taqsimlanishi orqali ta'minlanadi, bu esa kliniklarda mahsulotlar yetishmovchiligini bartaraf etadi.

Novo Integrated (NVOS) - Yalpi marja 04.07.2022dan 16.11.2024gacha

Novo Integrated Sciences (NVOS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Fundamental baholash:Novo Integrated Sciences
Novo Integrated Sciences Corp original mahsuloti

Novo Integrated Sciences (NVOS) biznes modeli barqaror ma'muriy yadroni saqlab qolgan holda, tibbiy xodimlarni ishga olish xarajatlariga bog'liq. Valo martjasi xizmatning har bir birligi uchun foyda ulushini aniqlash maqsadida umumiy daromaddan bevosita ishlab chiqarish xarajatlarini ayirish orqali ushbu samaradorlikni miqdoriy baholaydi. Valo foyda martjasini tahlil qilish investorga rahbariyatning buxgalteriya manevrlarini olib tashlash va qarz yuklamasidan qat'i nazar, aktivlarning real qiymatini baholash imkonini beradi.

Muhim raqobatchilar

HCA Holdings (HCA) - Yalpi marja|THC (tenethealth.com) - Yalpi marja|Yalpi marja Fresenius Medical|Yalpi foyda bo'yicha rentabellik SOLV (Solventum Health)|Yalpi foyda bo'yicha sotuv rentabelligi Encompass Health Corporation|Universal Health Services - Yalpi foyda bo'yicha rentabellik|DVA - Yalpi foyda bo'yicha rentabellik|RadNet Management - Yalpi marja|Yalpi foyda normasi OPCH (Option Care Health Inc)|Surgery Partners, Inc. (SGRY) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Premier|EYE (National Vision Holdings, Inc.) - Yalpi marja|Progyny Inc (PGNY) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ARDT|Yalpi rentabellik SEM (Select Medical Inc.)|Yalpi marja ASTH (Astrana Health, Inc.)|Yalpi marja Pediatrix Corp MD|USPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Pennant Group Inc|organogenesis.com (ORGO) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Nutex Health Inc.|Yalpi rentabellik aunainvestors.com|SBC: Yalpi foyda normasi|Yalpi marja EOLS|CYH - Yalpi foyda marjasi|Yalpi rentabellik The Beauty Health Company SKIN|Yalpi foyda koeffitsiyenti MDWD (MediWound Ltd.)|BTMD: Yalpi foyda bo'yicha rentabellik|thejoint.com - Yalpi foyda koeffitsiyenti|DCGO: Yalpi marja|P3 Health Partners Inc. (PIII) - Yalpi marja|Yalpi foyda bo'yicha rentabellik GANX|Yalpi foyda marjasi EUDA Health Holdings EUDA|Yalpi rentabellik Basel Medical Group Ltd (BMGL)|Yalpi foyda bo'yicha sotuv rentabelligi CollPlant Biotechnologies Ltd.|Cuprina Holdings - Yalpi foyda bo'yicha rentabellik|CCM - Yalpi foyda bo'yicha rentabellik|AMS - Yalpi rentabellik|MEDIROM Corp (MRM) - Yalpi foyda bo'yicha rentabellik|Avalon GloboCare Corporation (ALBT) - Yalpi rentabellik|Yalpi foyda marjasi DIH Holding US, Inc. (DHAI)|XAGE (carmellcosmetics.com) - Yalpi marja|NewGenIvf Group Ltd - Yalpi foyda bo'yicha marjinallik|Yalpi marja ATIP|CMAX (CareMax Medical Group) - Yalpi foyda normasi|Yalpi marja KDLY (kindlymd.com)|ModivCare Inc. (MODV) - Yalpi foyda marjasi|SSY - Yalpi rentabellik|BACK (IMAC Regeneration Centers) - Sotuvning yalpi rentabelligi